-
Can’t Get You Out of My Head: The Huntington’s Disease Symptom That’s More Than Just Repetition
5 min read
Latest News
-
AMT-130 at Four Years: Hopeful Signs, Complex Controls
12 min read
uniQure reports that after 4 years, people given high-dose AMT-130 continue to show signs of slower HD progression, providing hope for their recent regulatory submission. But the new analyses are nuanced. We unpack the hopeful, but complex results.
-
Double success for huntingtin RNAi gene silencing
9 min read
2 bits of good news for RNAi gene silencing in HD: it's safe over six months, and a way to treat bigger brain areas
-
New experiments clarify the role of SIRT1 in HD – or do they?
7 min read
Work from multiple labs suggests activating a protein called SIRT1 might help HD, but the picture is still confusing
-
Bone marrow transplantation in Huntington's Disease
5 min read
Bone marrow transplant protects HD mice from some symptoms, suggesting the immune system may be an important target
-
2011 – a year in Huntington's disease research
8 min read
Looking back at a year in Huntington's disease research – and the first year of HDBuzz
-
Gene therapy meets stem cells in liver disease success
6 min read
Scientists combine gene therapy and stem cells to correct a genetic liver disease. Could this combo be retooled for H
-
Chinese Huntington’s Disease Network launched
5 min read
Chinese Huntington’s Disease Network launched. Good news for China, good news for the global HD community
-
HDAC inhibitor drug protects memory in HD mice
8 min read
CBP, a gene-switching protein, protects memory in HD mice; 'histone deacetylase inhibitor' drug mimics its effects
-
Turning down the volume with dantrolene helps HD mice
5 min read
Dantrolene, an muscle-relaxer drug already on the market, helps HD mice by reducing cellular calcium levels
-
TRACK-HD reveals changes in HD mutation carriers, empowering future trials
7 min read
Follow-up data from TRACK-HD study proves that we have the tests we need to successfully run drug trials for HD
-
Huntexil hits the headlines again
3 min read
Huntexil makes headlines with science journal article, but nothing's changed: another trial is needed before approval
HDBuzz Trial Tracker
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
